Colgate-Palmolive Co (CL) Price

The P/E ratio of Colgate-Palmolive Co is 23.5864

Mr. Noel Wallace is the Chairman of the Board of Colgate-Palmolive Co, joining the firm since 2009.

The current price of CL is $81.18, it has decreased 0.42% in the last trading day.

Colgate-Palmolive Co belongs to Consumer products industry and the sector is Consumer Staples

Colgate-Palmolive Co's current market cap is $65.6B

According to wall street analysts, 24 analysts have made analyst ratings for Colgate-Palmolive Co, including 6 strong buy, 13 buy, 9 hold, 1 sell, and 6 strong sell

Updated: Mon, 15 Sep 2025 11:04:46 GMT UTC

Takeaway: Analysts are cautiously optimistic long-term but have recently trimmed near-term targets due to macroeconomic headwinds.

The Wall Street consensus for Colgate-Palmolive is a "Moderate Buy," reflecting belief in the company's fundamental strength. However, recent actions show tempered optimism. Following the Q2 2025 earnings report, several firms, including JPMorgan and Morgan Stanley, lowered their price targets to account for a more challenging consumer environment. While most revised targets remain above the current price, the downward trend signals near-term caution. The most bearish view comes from Wells Fargo, which maintains an "Underweight" rating and an $83 price target, citing risks from a slowdown in consumer spending.

Takeaway: The technical picture is bearish, with the price below key moving averages and showing negative risk-adjusted momentum.

Colgate-Palmolive's stock chart indicates a clear downtrend. The price is trading below both its 50-day moving average (MA) of approximately $86.12 and its 200-day MA of $89.80, a bearish signal for technicians.

• Key Indicators: The daily Relative Strength Index (RSI) is around 42.25, a neutral level that suggests the stock is not yet oversold and could have more room to fall.
• MACD: The Moving Average Convergence Divergence (MACD) line remains below its signal line, confirming the ongoing bearish momentum in the short term.
• Support Level: The stock is currently trading just above a key technical support level at $82.29. A break below this level could lead to further declines.

Takeaway: Ownership is dominated by passive funds, while active managers show no clear consensus, limiting strong buying pressure.

Colgate-Palmolive's shareholder base provides stability but lacks a strong bullish catalyst.

• Passive Dominance: The largest institutional holders are passive index funds, including Vanguard and SPDR S&P 500 ETFs. This ensures consistent demand as long as CL remains in major indices but also makes it susceptible to broad market outflows.
• Active Manager Division: Recent filings from active managers show conflicting views. T. Rowe Price Value Fund significantly reduced its position, while Diamond Hill Large Cap Fund increased its holding.
• Implication: This lack of a unified bullish thesis from active, conviction-driven investors means there is no strong institutional force to counteract the recent price weakness.

Takeaway: Trading volume patterns suggest institutional distribution, with higher volume on days the stock price falls.

An analysis of trading volume points toward a phase of methodical selling by larger investors rather than aggressive accumulation. While the stock's daily turnover rate is low, a closer look reveals that recent down-days have frequently occurred on higher-than-average volume. This pattern strongly implies a declining On-Balance Volume (OBV) trend, signaling that money is flowing out of the stock. This creates a persistent headwind for the share price as large holders appear to be reducing their positions over time.

Takeaway: Insider selling appears pre-planned and neutral, while the stock's significant ETF ownership provides stable but passive demand.

Recent insider and ETF activity does not point to a strong directional signal.

• Insider Selling: Recent sales by executives, including Chairman and CEO Noel Wallace, were executed under pre-scheduled Rule 10b5-1 trading plans. This suggests the sales are for personal financial planning and diversification rather than a negative outlook on the company's future, making the insider signal neutral.
• ETF Weighting: Colgate-Palmolive holds a significant 4.14% weight in the Consumer Staples Select Sector SPDR Fund (XLP). This provides a consistent source of passive demand for the stock, though it does not act as a catalyst for upward price movement.

Takeaway: The upcoming Q3 2025 earnings report is a critical catalyst that could shift the current bearish narrative.

The company's near-term valuation is heavily tied to its execution against macroeconomic uncertainty.

• Q3 Earnings: The most significant upcoming event is the Q3 2025 earnings report. It will be the first major update since management lowered guidance in Q2 and will be scrutinized for signs of stabilization in consumer demand.
• Strategic Initiatives: Recent positive news includes the declaration of a regular quarterly dividend of $0.52 per share and the launch of a new $300-$400 million productivity program to boost long-term growth.
• Innovation: The company also signed on to use an AI tool for developing new biomaterials for packaging, reinforcing its innovation narrative.

Takeaway: Macro concerns about a "cautious consumer" and geopolitical risks in key emerging markets are weighing on the stock.

External factors are a primary driver of the current cautious sentiment.

• Consumer Health: A key narrative highlighted by analysts is the "cautious consumer" in North America, which could pressure sales volumes and limit pricing power.
• Input Costs: The company remains exposed to volatility in raw material and packaging costs, which can compress margins if not fully offset by productivity gains or price increases.
• Geopolitical Risk: With over 70% of sales from outside the U.S., the company faces risks from foreign currency fluctuations and trade tensions. This includes potential disruption in key markets like India from nationalist marketing campaigns by local competitors.

Takeaway: Social media buzz is low and neutral-to-negative, while news flow is mixed, balancing operational challenges with strategic positives.

Sentiment surrounding Colgate-Palmolive is not driven by hype but by fundamental analysis. Social media discussion is low and oscillates between neutral and slightly negative, typical for a mature consumer staples company. Recent news flow reflects a dual narrative. Negative headlines focus on the "cautious consumer" and analyst price target cuts. In contrast, positive news highlights the company's consistent dividend payments, a new productivity program, and a recent endorsement from Jim Cramer, who noted the stock is at an attractive low level.

Colgate-Palmolive presents the case of a high-quality, financially robust company facing a challenging market environment. Its formidable competitive moat and disciplined capital allocation are currently being overshadowed by macroeconomic headwinds and a cautious consumer narrative. The stock's recent decline and bearish technical posture reflect this investor caution, creating a potential disconnect between its current market price and its long-term intrinsic value. The upcoming Q3 earnings report stands as the most critical near-term catalyst, with the potential to either validate fears of a slowdown or begin reversing the negative sentiment.